Literature DB >> 1356877

Analgesic effect of benzodiazepines and flumazenil.

F Sierralta1, H F Miranda.   

Abstract

1. In the present work the analgesic effect of benzodiazepines (BZD) and flumazenil (FLU) using the writhing test in mice was studied. 2. Intracerebroventricular administration of BZD exhibited a dose-dependent antinociceptive effect when compared to control value. 3. Intracerebroventricular administration of FLU induced a dose-dependent antinociceptive action that was not antagonized by naloxone (NX). 4. BZD administered as subcutaneous pellets produced an antinociceptive action in the writhing test, when compared to control mice, only at relative high doses and was partially antagonized by naloxone. 5. These findings could be explained assuming that NX and/or FLU have partial agonist properties in a common receptor which mediates the antinociceptive action. 6. The antinociceptive action of BZD could be related to an increased release of adenosine, which by itself has analgesic effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356877     DOI: 10.1016/0306-3623(92)90158-g

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  4 in total

1.  Enhancement by benzodiazepines of the inhibitory effect of adenosine on skeletal neuromuscular transmission.

Authors:  L C Chiou; J Y Ling; C C Chang
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

2.  Reversal of oxycodone and hydrocodone tolerance by diazepam.

Authors:  Maciej Gonek; Hamid I Akbarali; Graeme Henderson; William L Dewey
Journal:  Brain Res       Date:  2017-08-19       Impact factor: 3.252

3.  Novel Positive Allosteric Modulators of µ Opioid Receptor-Insight from In Silico and In Vivo Studies.

Authors:  Damian Bartuzi; Ewa Kędzierska; Agnieszka A Kaczor; Helmut Schmidhammer; Dariusz Matosiuk
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

4.  Reversal of morphine analgesic tolerance by ethanol in the mouse.

Authors:  L C Hull; B H Gabra; C P Bailey; G Henderson; W L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2013-03-25       Impact factor: 4.030

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.